Mr. Tang has more than 15 years of investment experience, with typical investment cases including Shanghai Lansheng Brain Hospital Group, Liangying Medical, Huaxi Bio (688363), Xinruipeng Pet Medical, Concentric Medical, and Soyuan Bio, etc. He has rich investment and industrial experience. Before founding Hosencare Brothers, Mr. Tang worked at Mitsui & Co. in Japan, a Fortune 500 company, since 2004, and was engaged in strategic investment in the consumer sector. Mr. Tang joined New Hope Group in 2009 and was responsible for overseas strategic cooperation and asset management business of various sectors and served as the front office head and managing director of Hou Sheng Investment.
Mr. Tang holds a master's degree in economics from Peking University and has been honored as one of the "2018 China's Top 10 Outstanding Venture Capitalists" by Beijing Venture Capital Association and "2015 China's Top 10 Best Emerging Investors" by Invest China.
He is also a member of the Advisory Committee for Industrial Development of West Lake Pharmaceutical College and a member of Suzhou Industrial Park Young Entrepreneurs Association.